Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries.
Hilberg O, Hoffmann-Vold AM, Smith V, Bouros D, Kilpeläinen M, Guiot J, Morais A, Clemente S, Daniil Z, Papakosta D, Fretheim H, Neves S, Alfaro TM, Antoniou KM, Valveny N, Asijee G, Soulard S, Wuyts W. Hilberg O, et al. Among authors: soulard s. ERJ Open Res. 2022 Jan 24;8(1):00597-2021. doi: 10.1183/23120541.00597-2021. eCollection 2022 Jan. ERJ Open Res. 2022. PMID: 35083316 Free PMC article.
The Burden of Progressive Fibrosing Interstitial Lung Disease: A DELPHI Approach.
Wuyts WA, Papiris S, Manali E, Kilpeläinen M, Davidsen JR, Miedema J, Robalo-Cordeiro C, Morais A, Artés M, Asijee G, Cendoya D, Soulard S. Wuyts WA, et al. Among authors: soulard s. Adv Ther. 2020 Jul;37(7):3246-3264. doi: 10.1007/s12325-020-01384-0. Epub 2020 May 22. Adv Ther. 2020. PMID: 32445186 Free PMC article.
Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study.
Davidsen JR, Miedema J, Wuyts W, Kilpeläinen M, Papiris S, Manali E, Robalo Cordeiro C, Morais A, Pérez M, Asijee G, Cendoya D, Soulard S. Davidsen JR, et al. Among authors: soulard s. Adv Ther. 2021 Jan;38(1):521-540. doi: 10.1007/s12325-020-01541-5. Epub 2020 Nov 6. Adv Ther. 2021. PMID: 33156462 Free PMC article.
The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.
Souliotis K, Silva Miguel L, Hillas G, Borges M, Papageorgiou G, Viana D, Malhadeiro J, Soulard S. Souliotis K, et al. Among authors: soulard s. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620926802. doi: 10.1177/1753466620926802. Ther Adv Respir Dis. 2020. PMID: 32519591 Free PMC article.
Reducing carbon footprint by switching to reusable soft-mist inhalers.
Janson C, Hernando Platz J, Soulard S, Langham S, Nicholson L, Hartgers-Gubbels ES. Janson C, et al. Among authors: soulard s. ERJ Open Res. 2023 May 2;9(3):00543-2022. doi: 10.1183/23120541.00543-2022. eCollection 2023 Jul. ERJ Open Res. 2023. PMID: 37143844 Free PMC article.
I-PreFer Study: A Discrete Choice Experiment to Explore Patient, Caregiver and Pulmonologist Preferences of Idiopathic Pulmonary Fibrosis Pharmacological Treatment Options.
Hollmen M, Wijsenbeek M, Bromilow T, Smith AB, Mealing S, Lewis D, Galvin L, Jones S, Asijee G, Soulard S, Froidure A. Hollmen M, et al. Among authors: soulard s. Patient Prefer Adherence. 2023 Aug 4;17:1895-1906. doi: 10.2147/PPA.S409767. eCollection 2023. Patient Prefer Adherence. 2023. PMID: 37560147 Free PMC article.
15 results